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Background: Penicillium species are among the most common fungi present in the environment and are usually
considered non-pathogenic to humans. However, in immunocompromised hosts they can be virulent pathogens
and can cause death. Penicillium digitatum is a plant pathogen that commonly causes a postharvest fungal disease
of citrus called green mould; it very rarely causes systemic mycosis in humans. Here, we report a case of fatal
pneumonia due to P. digitatum infection, as confirmed by repeated examination of cultured sputum.
Case presentation: A cavity was found in the left upper lung on routine chest X-ray in a 78-year-old
undernourished male who had been diagnosed at age 66 with bronchial asthma and pulmonary emphysema. No
increased sputum production was present. The presence of antigen-specific precipitating antibodies to Aspergillus
flavus and P. digitatum was confirmed in the patient’s serum and also later pleural fluid by using Ouchterlony
double immunodiffusion testing with A. flavus and P. digitatum antigens. The patient was treated over a period of
months with itraconazole, micafungin, voriconazole, amphotericin B, and antibacterials. However, the cavity
enlarged, the pleural effusion increased, and the patient began producing purulent sputum. He died from
progressive renal failure. From sputum culture only one fungus was isolated repeatedly on potato-dextrose agar in
large quantities. This fungus was confirmed to be P. digitatum by molecular identification. Partial sequences of the
beta-tubulin gene were determined by using the primers Bt2a and Bt2b for PCR amplification and sequencing and
underwent a BLAST search at the National Centre for Biotechnology Information, these results confirmed that the
isolated fungus was P. digitatum.
Conclusion: To our knowledge, this is the first report of pulmonary infection with P. digitatum. Our patient had
pulmonary emphysema and was elderly, and undernourished. These factors might have facilitated the infection. In
his case, antimycotics were ineffective in treating the lung involvement. Although human infection with P.
digitatum is considered rare, it appears that this organism can be very virulent and resistant to antimycotics.
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PneumoniaBackground
Penicillium species are among the most common fungi in
the environment and are usually considered non-pathogenic
to humans [1]. However, in immunocompromised hosts
they can be virulent pathogens that can cause death [2].
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reproduction in any medium, provided the orcauses a postharvest fungal disease of citrus called green
mould [1]; it very rarely causes systemic mycosis in
humans [3]. Here, we report a case of fatal pneumonia
due to P. digitatum infection, as confirmed by repeated
examination of cultured sputum.
Case presentation
A 78-year-old male presented at our hospital in April
2005 with a history of bronchial asthma and pulmonary
emphysema first diagnosed at age 66 years. He had been
an office worker for 40 years and had never been in-
volved in agriculture. He had therefore had no obviousl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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work environment or in and around his house. His
asthma was of the non-atopic type and moderate, as de-
fined by the Global Initiative for Asthma Guidelines
2002. The patient was an ex-smoker with a Brinkman
Index of 1590. He was being treated with inhaled corti-
costeroids and theophylline. On first presentation in
April 2005 to our hospital, he did not have asthma
exacerbation or increased sputum production, but his
dyspnoea on effort was graded 2 on the Hugh–Jones
scale. In April 2005, when the patient was 78 years old,
an abnormal shadow representing a cavity was found in
the left upper lung on chest X ray at his yearly medical
check-up. At the time the patient did not have increased
sputum production, but chest computed tomography
(CT) revealed a thin-walled cavity about 4 cm across and
containing a fungus ball in the left upper lobe (S1 + 2); a
CT scan taken 2 years previously had revealed only a
small cavity indicative of emphysematous change
(Figures 1a, 1b). There were no inflammatory changes
in the peripheral blood (leukocyte count, 7950 cells/μL;
C-reactive protein, 0.23 mg/dL; erythrocyte sedimenta-
tion rate, 10 mm/h; Aspergillus antigen, negative; β-D
glucan, negative), but antigen-specific precipitating
antibodies to Aspergillus flavus and P. digitatum were
confirmed in the patient’s serum and pleural fluid by
Ouchterlony double immunodiffusion testing [4]. No A.
flavus or P. digitatum and no bacteria or tubercle
bacilli were detected in cultures of sputum or bronchial
lavage fluids. We diagnosed the patient with lung
aspergilloma and treated with itraconazole (100 mg/day)Figure 1 Computed tomographic imaging of the chest at the level of the
cavity in the left upper lobe due to emphysematous change (a). Compute
that the cavity was increasing in size and contained a fungus ball (b). The
infiltration of the surrounding areas, with increased pulmonary effusion (c:for 3 months. However, the cavity became larger and
thicker-walled (Figure 1c, July 2005), and the patient de-
veloped back pain. He was admitted to our hospital on 25
July 2005 and was treated for 3 months with an increased
dose of itraconazole (200 mg/day) with added micafungin
(300 mg/day). The patient’s vital capacity (VC) of 2.64 L,
percentage VC of 85.7%, forced expiratory volume in 1 s
(FEV1) of 1.09 L, and percentage FEV1 of 50.9% in August
2005 was lower than his VC of 3.01 L,%VC of 95.6%,
FEV1 of 1.12 L,%FEV1 of 49.6% in 2003. The patient was
unable to undergo further lung function tests because of
his progressive respiratory failure.
The cavity continued to enlarge further. Its fluid content
increased, and consolidation appeared around it (Figure 1d,
October 2005). The patient’s medication regimen was
changed to voriconazole (400 mg/day), amphotericin B
(10 mg/day), and fluconazole (400 mg/day), in addition to
itraconazole (200 mg/day) and antibacterials. Treatment
with this broad range of antimycotics and antibiotics did
not slow the growth of the cavity: its fluid content contin-
ued to increase, and invasive consolidation and pleural
effusion developed (Figure 1e, December 2005; 1f, January
2006). The pleural effusion increased, and the patient
began producing purulent sputum. He died in February
2006 from progressive renal failure. Sputum samples
yielded a single fungus, which was isolated repeatedly on
potato-dextrose agar in large quantities. It was identified as
P. digitatum and had the form of a spreading organism
with a mealy, grey-green colour that turned olive green in
culture. The abundance of the organism’s elliptical spores
was greater in the patient’s sputum culture (Figure 2) thanaortic arch in 2003, two years before dyspnea onset, showed a small
d tomography 2 years after initial presentation (April 2005) showed
cavity then continued to increase in size, developing a thick wall and
July 2005; d: October 2005; e: December 2005; f: January 2006).
Figure 2 The fruiting structures (penicilli) of Penicillium from
this patient have a brush-like appearance; the spores of
Penicillium digitatum are typically elliptical under
the microscope.
Oshikata et al. BMC Pulmonary Medicine 2013, 13:16 Page 3 of 4
http://www.biomedcentral.com/1471-2466/13/16in cultured reference colonies [1]. This fungus was con-
firmed to be P. digitatum by molecular identification. Par-
tial sequences of the β-tubulin gene determined by using
the primers Bt2a and Bt2b [5] underwent BLAST analysis
at the National Centre for Biotechnology Information.
We found antigen-specific precipitating antibodies to
A. flavus and P. digitatum in the patient’s serum
(Figure 3a) at April 2005.and pleural effusion at Novem-
ber 2005 by using Ouchterlony double immunodiffusion
testing [4] with A. flavus and P. digitatum antigens
(HollisterStier, Spokane, WA, USA). We confirmed theFigure 3 Antigen-specific precipitating antibodies to Aspergillus flavu
by Ouchterlony double immunodiffusion testing with A. flavus and P.
precipitating antibodies to P. digitatum by using antigen derived from the
sputum (b).presence of antigen-specific precipitating antibodies to
P digitatum by using antigen derived from the patient’s
sputum culture fluid or extracted directly from his spu-
tum (Figure 3b).
To extract the antigen from the sputum culture, we
added 1.5 mL of Glass Beads (Biospec Product, OK,
USA) to the patient’s sputum and crushed the mixture
with a Mini-Beadbeater (Biospec Product, OK, USA). It
was then incubated with 0.125 mol of NH4CO3 over-
night at 4°C and the antigen extracted after freeze-
drying of the filtrate. We diagnosed invasive pulmonary
penicilliosis due to P. digitatum.
Discussion
Penicillium digitatum is the most devastating pathogen
of rotten citrus fruit and is responsible for 90% of pro-
duction losses during post-harvest handling [6]. Penicil-
lium digitatum is widely distributed in soils throughout
the world. People are commonly exposed to the spores
of this airborne pathogen every day. Upon Ouchterlony
double immunodiffusion testing, the sera of five of 770
patients with pulmonary lung disease were confirmed to
have low titres of antigen-specific precipitating anti-
bodies to P. digitatum against antigen (obtained from
Greer Laboratories, Lenoir, NC). However, none of these
patients had antigen-specific precipitating antibodies to
P. digitatum in tests of antigen extracted from patient’
sputum culture fluid or sputum. In humans there is
cross-reactivity to Aspergillus and Penicillium: most sera
from patients with precipitins against Penicillium have
precipitins against Aspergillus [7]. In April 2005, ours and Penicillium digitatum in the patient’s serum (a) were found
digitatum antigens. We confirmed the presence of antigen-specific
patient’s sputum culture fluid or extracted from the fungus in his
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flavus, but we did not find any P. digitatum or A. flavus
in sputum cultures or in bronchoalveolar lavage fluids.
This led to a delay in diagnosis.
Penicillium species can cause opportunistic infections
[2]. Patients with Penicillium species infections have been
treated successfully with itraconazole [8], amphotericin B
[3,9], or fluconazole [3]. However, some patients with con-
ditions caused by Penicillium species have died despite
treatment with ketoconazole [2], amphotericin B [2], or
itraconazole [10]. Pulmonary infections with fungi, includ-
ing Penicillium species, are associated with much higher
mortality rates in patients with nosocomial infections or
infections complicating organ failure [11]. The minimal
inhibitory concentrations of amphotericin B, itraconazole,
posaconazole, ravuconazole, and voriconazole against A.
flavus or Aspergillus fumigatus are lower than those
against Penicillium spp. [12].
Conclusions
To our knowledge, this is the first report of pulmonary
infection with P. digitatum. Our patient had pulmonary
emphysema and was elderly, and undernourished. He
had no known history of exposure to citrus fruit patho-
gens, but he was likely to have been immunocomprom-
ised. These factors might have facilitated the infection.
In his case, antimycotics were ineffective in treating the
lung involvement. Although human infections with P.
digitatum are considered rare, it appears that this organ-
ism can be very virulent and resistant to antimycotics.
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